tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MAZE Stock Latest News

Maze Therapeutics price target raised to $46 from $34 at Guggenheim
The FlyMaze Therapeutics price target raised to $46 from $34 at Guggenheim
3d ago
MAZE
Maze Therapeutics initiated with an Overweight at Wells Fargo
PremiumThe Fly
Maze Therapeutics initiated with an Overweight at Wells Fargo
18d ago
MAZE
Maze Therapeutics price target raised to $60 from $50 at H.C. Wainwright
PremiumThe Fly
Maze Therapeutics price target raised to $60 from $50 at H.C. Wainwright
19d ago
MAZE
Maze Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe Fly
Maze Therapeutics initiated with a Strong Buy at Raymond James
1M ago
MAZE
Maze Therapeutics Reports Strong Q3 2025 Progress
PremiumCompany Announcements
Maze Therapeutics Reports Strong Q3 2025 Progress
1M ago
MAZE
Promising Developments in Maze Therapeutics’ Pipeline: Buy Rating Reinforced by MZE829 and MZE782 Advances
PremiumRatingsPromising Developments in Maze Therapeutics’ Pipeline: Buy Rating Reinforced by MZE829 and MZE782 Advances
2M ago
MAZE
Maze Therapeutics reports Q3 EPS (66c), consensus (69c)
Premium
The Fly
Maze Therapeutics reports Q3 EPS (66c), consensus (69c)
2M ago
MAZE
Maze Therapeutics Advances Kidney Disease Treatment with MZE829 Study
Premium
Company Announcements
Maze Therapeutics Advances Kidney Disease Treatment with MZE829 Study
2M ago
MAZE
Maze Therapeutics files to sell 9.23M shares of common stock for holders
PremiumThe Fly
Maze Therapeutics files to sell 9.23M shares of common stock for holders
2M ago
MAZE
Maze Therapeutics Appoints Hervé Hoppenot as Chairman
PremiumCompany Announcements
Maze Therapeutics Appoints Hervé Hoppenot as Chairman
3M ago
8K
MAZE
Maze Therapeutics appoints Herve Hoppenot as chairman of the board
PremiumThe Fly
Maze Therapeutics appoints Herve Hoppenot as chairman of the board
3M ago
INCY
MAZE
Two new option listings on September 17th
PremiumThe Fly
Two new option listings on September 17th
3M ago
MAZE
WYFI
Maze Therapeutics price target raised to $34 from $19 at Guggenheim
PremiumThe FlyMaze Therapeutics price target raised to $34 from $19 at Guggenheim
3M ago
MAZE
Maze Therapeutics price target raised to $50 from $34 at H.C. Wainwright
Premium
The Fly
Maze Therapeutics price target raised to $50 from $34 at H.C. Wainwright
3M ago
MAZE
Maze Therapeutics Advances Clinical Programs Amid Financial Stability
Premium
Company Announcements
Maze Therapeutics Advances Clinical Programs Amid Financial Stability
3M ago
MAZE
Maze Therapeutics price target raised to $37 from $30 at BTIG
PremiumThe Fly
Maze Therapeutics price target raised to $37 from $30 at BTIG
3M ago
MAZE
Maze Therapeutics price target raised to $34 from $28 at Leerink
PremiumThe Fly
Maze Therapeutics price target raised to $34 from $28 at Leerink
3M ago
MAZE
Kroger reports mixed Q2, U.S. CPI rises 0.4% in August: Morning Buzz
PremiumThe Fly
Kroger reports mixed Q2, U.S. CPI rises 0.4% in August: Morning Buzz
3M ago
KR
CNC
Maze Therapeutics Secures $150M in Private Placement
PremiumCompany Announcements
Maze Therapeutics Secures $150M in Private Placement
3M ago
8K
MAZE
Maze Therapeutics announces results from Phase 1 trial of MZE782
PremiumThe FlyMaze Therapeutics announces results from Phase 1 trial of MZE782
3M ago
MAZE
Maze Therapeutics prices 4M shares at $16.25 in private placement
Premium
The Fly
Maze Therapeutics prices 4M shares at $16.25 in private placement
3M ago
MAZE
Maze Therapeutics Appoints Misbah Tahir as CFO
Premium
Company Announcements
Maze Therapeutics Appoints Misbah Tahir as CFO
4M ago
8K
MAZE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >